{"sha1": "cf7523995f35ab55ab813f57d643a1eec422d55d", "filename_exif": "4140.txt", "extension_exif": "TXT", "last_modified_exif": "2021:09:23 16:30:10+10:00", "create_date_exif": null, "access_date_exif": "2023:09:23 14:24:05+10:00", "modify_date_exif": "2021:09:23 16:30:10+10:00", "mime_type_exif": "text/plain", "file_size_exif": 16663, "title_exif": "", "path_components_exif": ["data", "medical_papers"], "publication_date_exif": "", "author_exif": "", "organizational_unit_exif": "", "content": "\n\n\n\n\n\n\n\n\n\n\u300a\u5b9e\u7528\u5668\u5b98\u79fb\u690d\u7535\u5b50\u6742\u5fd7\u300b2019 \u5e74 7 \u6708\u7b2c 7 \u5377\u7b2c 4 \u671f Prac J Organ Transplant (Electronic Version), July 2019, Vol.7, No.4\r\n-317\u30fb\r\n.\u7efc\u8ff0.\r\n\u80ba\u79fb\u690d\u672f\u540e\u6cbb\u7597\u7684\u7814\u7a76\u8fdb\u5c55\r\n\u9093\u6dd1\u5764\uff0c\u9f9a\u71d5\u534e\uff0c\u5468\u4ef2\u534e\uff0c\u8881\u9e4f\uff08\u65e0\u9521\u5e02\u4eba\u6c11\u533b\u9662\u5eb7\u590d\u533b\u5b66\u79d1,\u6c5f\u82cf \u65e0\u9521 214023\uff09\r\n\u80ba\u79fb\u690d\u662f\u76ee\u524d\u4e34\u5e8a\u6cbb\u7597\u7ec8\u672b\u671f\u80ba\u75c5\u7684\u552f\u4e00\u6709\u6548 \u65b9\u5f0f\uff3b1\uff3d,\u80ba\u79fb\u690d\u672f\u540e\u5b58\u6d3b\u7387\u5728\u5b9e\u4f53\u5668\u5b98\u79fb\u690d\u4e2d\u6700\u4f4e\u3002 \u6839\u636e\u56fd\u9645\u5fc3\u80ba\u79fb\u690d\u534f\u4f1a2015\u5e74\u7684\u62a5\u544a,\u5168\u7403\u5df2\u5b8c \u621051 440\u591a\u4f8b\u80ba\u79fb\u690d\u624b\u672f,\u80ba\u79fb\u690d\u672f\u540e3\u4e2a\u6708\u30011\u5e74\u3001 3\u5e74\u30015\u5e74\u548c10\u5e74\u7684\u5b58\u6d3b\u7387\u5206\u522b\u4e3a89\uff05\u300180\uff05\u3001 65\uff05\u300154\uff05\u548c31\uff05\uff3b2\uff3d\u3002\u7531\u4e8e\u514d\u75ab\u6291\u5236\u5242\u7684\u5e94\u7528, \u80ba\u79fb\u690d\u53d7\u4f53\u957f\u671f\u5904\u4e8e\u514d\u75ab\u6291\u5236\u72b6\u6001,\u4e14\u80ba\u79fb\u690d\u7684\u514d \u75ab\u6291\u5236\u5242\u7ef4\u6301\u5242\u91cf\u4e3a\u6240\u6709\u5668\u5b98\u79fb\u690d\u4e2d\u6700\u9ad8,\u6709\u611f \u67d3\u98ce\u9669\u3002\u4f9b\u80ba\u53bb\u795e\u7ecf\u652f\u914d\u3001\u7ea4\u6bdb\u8fd0\u52a8\u51cf\u5f31\u3001\u54b3\u55fd \u53cd\u5c04\u51cf\u5f31,\u53d7\u4f53\u672f\u524d\u57fa\u7840\u60c5\u51b5\u5dee\u3001\u8425\u517b\u4e0d\u826f,\u672f\u540e \u7f6e\u5165\u8f83\u591a\u7ba1\u9053,\u8fd9\u4e9b\u56e0\u7d20\u5747\u4f7f\u53d7\u4f53\u6b7b\u4ea1\u7387\u589e\u52a0\uff3b3\uff3d\u3002 \u67e5\u9605\u8fd1\u5e74\u6765\u6587\u732e\u53d1\u73b0,\u5173\u4e8e\u80ba\u79fb\u690d\u672f\u540e\u7684\u5e72\u9884\u6cbb\u7597 \u8f83\u7247\u9762\u5355\u4e00,\u7f3a\u4e4f\u5168\u9762\u7cfb\u7edf\u7684\u8bba\u8ff0\u3002\u56e0\u6b64,\u672c\u6587\u901a \u8fc7\u603b\u7ed3\u80ba\u79fb\u690d\u672f\u540e\u7684\u6cbb\u7597\u65b9\u6cd5,\u4ee5\u6307\u5bfc\u53d7\u4f53\u5eb7\u590d\u6cbb \u7597\u3001\u63d0\u9ad8\u53d7\u4f53\u7684\u751f\u5b58\u7387\u53ca\u751f\u5b58\u8d28\u91cf\u3002\r\n1\t\u80ba\u79fb\u690d\u672f\u540e\u836f\u7269\u6cbb\u7597\r\n\u80ba\u79fb\u690d\u672f\u540e\u7684\u836f\u7269\u6cbb\u7597\u6700\u4e3a\u5e38\u89c1,\u4e3b\u8981\u5305\u62ec\u514d \u75ab\u6291\u5236\u5242\u3001\u9884\u9632\u6027\u6297\u611f\u67d3\u836f\u7269\u4ee5\u53ca\u5176\u4ed6\u76f8\u5173\u836f\u7269\u3002\r\n\u80ba\u79fb\u690d\u672f\u540e\u514d\u75ab\u6291\u5236\u7684\u8bf1\u5bfc\u548c\u7ef4\u6301\u53ef\u9632\u6b62\u80ba \u540c\u79cd\u5f02\u4f53\u79fb\u690d\u7269\u7684\u6025\u3001\u6162\u6027\u6392\u65a5\u53cd\u5e94,\u5e38\u89c4\u4f7f\u7528 \u7cd6\u76ae\u8d28\u6fc0\u7d20\uff08 \u6fc0\u7d20\uff09+\u9499\u8c03\u78f7\u9178\u9176\u6291\u5236\u5242\u3014\u73af\u5b62 \u7d20 A \uff08 cyclosporin A, CsA \uff09\u6216\u4ed6\u514b\u83ab\u53f8\uff08tacrolimus, Tac \uff09\u3015+\u6838\u82f7\u9178\u963b\u65ad\u5242\u3014\uff08\u9709\u915a\u9178\u916f\uff08mycophenolate mofetil, MMF\uff09\u6216\u786b\u5511\u560c\u5464\uff09\u3015\u4e09\u8054\u7597\u6cd5\u7ef4\u6301R \u5bf9\u4e8e\u4e0d\u80fd\u8010\u53d7\u9499\u8c03\u78f7\u9178\u9176\u6291\u5236\u5242\u7684\u53d7\u4f53,\u96f7\u5e15\u9709 \u7d20\u6291\u5236\u5242\u897f\u7f57\u83ab\u53f8\u548c\u4f9d\u7ef4\u83ab\u53f8\u53ef\u4f5c\u4e3a\u6f5c\u5728\u66ff\u4ee3\u836f \u7269\uff0c\u3002Strueber\u7b49\u2479\u901a\u8fc7\u5bf9190\u4f8b\u80ba\u79fb\u690d\u53d7\u4f53\u8fdb\u884c \u4f9d\u7ef4\u83ab\u53f8+ CsA +\u6fc0\u7d20\uff08\u4f9d\u7ef4\u83ab\u53f8\u7ec4\uff09\u4ee5\u53caMMF + CsA +\u6fc0\u7d20\uff08\u5bf9\u7167\u7ec4\uff09\u4e24\u79cd\u4e0d\u540c\u514d\u75ab\u6291\u5236\u65b9\u6848\u8fdb \u884c\u5bf9\u6bd4,\u53d1\u73b0\u4f9d\u7ef4\u83ab\u53f8\u7ec4\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408 \u5f81\u7684\u53d1\u751f\u7387\u660e\u663e\u4f4e\u4e8e\u5bf9\u7167\u7ec4\u3002Gullestad\u7b49\u247a\u53d1\u73b0 \u4f9d\u7ef4\u83ab\u53f8\u6709\u52a9\u4e8e\u7ef4\u6301\u80be\u5c0f\u7403\u6ee4\u8fc7\u7387\u7684\u7a33\u5b9a\u3002\u7136\u800c,\r\nDOI\uff1a10.3969/j.issn.2095-5332.2019.04.019\r\n\u57fa\u91d1\u9879\u76ee\uff1a\u5357\u4eac\u533b\u79d1\u5927\u5b66\u79d1\u6280\u53d1\u5c55\u57fa\u91d1\u9879\u76ee\uff08NMUB2018359\uff09\r\n\u901a\u8baf\u4f5c\u8005:\u8881\u9e4f\uff0cEmail \uff1ayuanpeng_1993@163.com\r\n\u96f7\u5e15\u9709\u7d20\u6291\u5236\u5242\u4f1a\u5bfc\u81f4\u80ba\u6bd2\u6027\u53ca\u9759\u8109\u8840\u6813\u6813\u585e, Ahya\u7b49\u247b\u6307\u51fa\u897f\u7f57\u83ab\u53f8\u4f1a\u589e\u52a0\u9759\u8109\u8840\u6813\u6813\u585e\u75c7\u7684 \u53d1\u751f\u7387\u3002\u4e5f\u6709\u5b66\u8005\u5bf9\u80ba\u79fb\u690d\u53d7\u4f53\u8fdb\u884cCsA + MMF + \u6fc0\u7d20\uff08CsA\u7ec4\uff09\u4ee5\u53caTac + MMF +\u6fc0\u7d20\uff08Tac\u7ec4\uff09 \u4e24\u79cd\u4e0d\u540c\u514d\u75ab\u6291\u5236\u65b9\u6848\u6bd4\u8f83\uff0c\u968f\u8bbf3\u5e74\u540e\u53d1\u73b0Tac \u7ec4\u7684\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408\u5f81\u53d1\u751f\u7387\u663e\u8457\u964d\u4f4e, \u4f46\u4e24\u7ec4\u95f4\u6025\u6027\u6392\u65a5\u53cd\u5e94\u53d1\u751f\u7387\u53ca\u5b58\u6d3b\u7387\u65e0\u663e\u8457\u6027\u5dee \u5f02 \u4f46\u662f\u5728\u79fb\u690d\u672f\u540e\u7684\u968f\u8bbf\u4e2d\uff0cTac\u548cCsA\u90fd\u4e0e\u80be \u529f\u80fd\u8870\u7aed\u6709\u5173,\u56e0\u6b64\u5728\u8f7b\u5ea6\u6025\u6027\u80be\u635f\u4f24\u7684\u53d7\u4f53\u4e2d, \u5efa\u8bae\u5728\u5bc6\u5207\u76d1\u6d4b\u4e0b\u5c06\u836f\u7269\u6c34\u5e73\u4fdd\u6301\u5728\u6cbb\u7597\u8303\u56f4\u7684\u4e0b \u9650,\u800c\u4e25\u91cd\u6216\u6301\u7eed\u6027\u80be\u529f\u80fd\u4e0d\u5168\u7684\u53d7\u4f53\u5219\u9700\u8981\u6682\u505c \u836f\u7269\uff3b9-10\uff3d\u3002\r\n\u80ba\u79fb\u690d\u53d7\u4f53\u5bb9\u6613\u7ee7\u53d1\u611f\u67d3\u5e76\u53d1\u75c7,\u672f\u540e\u901a\u5e38\u9700 \u8981\u9884\u9632\u6027\u4f7f\u7528\u6297\u611f\u67d3\u836f\u7269\uff3b11\uff3d\u3002\u80ba\u79fb\u690d\u53d7\u4f53\u60a3\u7ec6\u83cc \u611f\u67d3\u3001\u75c5\u6bd2\u611f\u67d3\uff08\u5de8\u7ec6\u80de\u75c5\u6bd2\uff09\u548c\u771f\u83cc\u611f\u67d3\uff08\u66f2 \u9709\u83cc\u548c\u5ff5\u73e0\u83cc\u5c5e\uff09\u7684\u98ce\u9669\u6781\u5927,\u5176\u4e2d\u7ec6\u83cc\u6027\u80ba\u708e \u6700\u5e38\u89c1\u3002\u7532\u6c27\u82c4\u6c28\u5627\u5576-\u78fa\u80fa\u7532\u6076\u5511\uff08TMP-SMX\uff09 \u6216\u6c28\u82ef\u781c\u53ef\u4ee5\u9884\u9632\u80ba\u79fb\u690d\u53d7\u4f53\u7684\u80ba\u56ca\u866b\u80ba\u708e\uff3b12\uff3d\u3002 \u4f46TMP-SMX\u53ef\u80fd\u5bfc\u81f4\u7535\u89e3\u8d28\u5f02\u5e38\u3001\u8840\u6db2\u6076\u6db2\u8d28\u3001 \u76ae\u80a4\u75c5\u5b66\u53cd\u5e94\u548c\u809d\u574f\u6b7b\uff0c\u5bf9\u4e0d\u80fd\u8010\u53d7TMP-SMX\u526f \u4f5c\u7528\u6216\u78fa\u80fa\u8fc7\u654f\u7684\u53d7\u4f53,\u53ef\u5c06\u6c28\u82ef\u781c\u4f5c\u4e3a\u66ff\u4ee3\u54c1 \u8fdb\u884c\u9884\u9632\u6027\u6cbb\u7597\uff3b13\uff3d\u3002\u7f2c\u66f4\u6614\u6d1b\u97e6\u53ef\u9884\u9632\u5de8\u7ec6\u80de\u75c5\u6bd2 \u611f\u67d3\uff0c\u6839\u636e\u8840\u6e05\u5b66\u72b6\u6001\u53ef\u6301\u7eed\u6cbb\u75976 ~12\u4e2a\u6708\u53e34\u3015\uff0c \u4f46\u662f\u7f2c\u66f4\u6614\u6d1b\u97e6\u5177\u6709\u80be\u6bd2\u6027\u548c\u81f4\u7578\u6027\u3002\u96fe\u5316\u4e24\u6027\u9709 \u7d20B\u7528\u4e8e\u9884\u9632\u771f\u83cc\u611f\u67d3\uff0c\u5305\u62ec\u547c\u5438\u9053\u65e0\u66f2\u9709\u83cc\u5b9a \u690d\u7684\u80ba\u79fb\u690d\u53d7\u4f53\uff3b15\uff3d,\u800c\u4f0f\u7acb\u5eb7\u5511\u4e3b\u8981\u7528\u4e8e\u5df2\u77e5\u771f \u83cc\u5b9a\u690d\u7684\u53d7\u4f53\uff0c\u4e24\u6027\u9709\u7d20B\u5177\u6709\u80be\u6bd2\u6027\u3001\u53ef\u5bfc\u81f4 \u81f4\u7535\u89e3\u8d28\u5f02\u5e38,\u4f0f\u7acb\u5eb7\u5511\u4e0e\u5fc3\u5f8b\u5931\u5e38\u3001\u809d\u6bd2\u6027\u548c \u80be\u6bd2\u6027\u6709\u5173\uff3b16\uff3d\u3002\u503c\u5f97\u6ce8\u610f\u7684\u662f,\u5728\u80ba\u79fb\u690d\u53d7\u4f53\u4e2d \u8fd9\u7c7b\u6297\u771f\u83cc\u836f\u7269\u53ef\u80fd\u4e0e\u5176\u4ed6\u5e38\u7528\u836f\u7269\u6709\u663e\u8457\u76f8\u4e92 \u4f5c\u7528\uff0c\u4f8b\u5982\u4f0f\u7acb\u5eb7\u5511\u53ef\u80fd\u4f1a\u589e\u52a0Tac\u7684\u8840\u836f\u6d53\u5ea6\uff0c \u5e76\u53ef\u80fd\u4f1a\u964d\u4f4eCsA\u7684\u4ee3\u8c221\u247a\uff0c\u56e0\u6b64\uff0c\u4f7f\u7528\u4f0f\u7acb\u5eb7 \u5511\u7b49\u8fdb\u884c\u6297\u611f\u67d3\u6cbb\u7597\u65f6\u5fc5\u987b\u76d1\u6d4b\u514d\u75ab\u6291\u5236\u5242\u7684\u8840\u836f \u6d53\u5ea6\u3002\r\n\u80ba\u79fb\u690d\u53d7\u4f53\u672f\u540e\u4e5f\u5305\u62ec\u5176\u4ed6\u836f\u7269\u7684\u5e72\u9884\u6cbb\u7597\u3002 Moreno\u7b49\u53e381\u5728\u80ba\u79fb\u690d\u672f\u5f00\u59cb\u65f6\u81f348 h\u7ed9\u4e88\u53d7\u4f53\r\n\u2022318\u30fb\r\n\u300a\u5b9e\u7528\u5668\u5b98\u79fb\u690d\u7535\u5b50\u6742\u5fd7\u300b2019 \u5e74 7 \u6708\u7b2c 7 \u5377\u7b2c 4 \u671f Prac J Organ Transplant (Electronic Version), July 2019, Vol.7, No.4\r\n\u6301\u7eed\u5438\u5165\u4e00\u6c27\u5316\u6c2e\uff0c\u4e8e12 h\u300124 h\u5206\u522b\u91c7\u96c6\u53d7\u4f53\u7684 \u5916\u5468\u52a8\u8109\u8840\u53ca\u80ba\u704c\u6d17\u6db2,\u68c0\u6d4b\u53d1\u73b0\u5438\u5165\u4e00\u6c27\u5316\u6c2e\u7684 \u53d7\u4f53\u767d\u4ecb\u7d20-6\u30018\u6c34\u5e73\u4ee5\u53ca\u539f\u53d1\u6027\u79fb\u690d\u7269\u529f\u80fd\u969c \u788d\u53d1\u751f\u7387\u660e\u663e\u4f4e\u4e8e\u5bf9\u7167\u7ec4\u3002Hartwig\u7b491\u53e3\u6307\u51fa\u91c7\u7528 \u5154\u6297\u80f8\u817a\u7ec6\u80de\u7403\u86cb\u767d\u8bf1\u5bfc\u7597\u6cd5\u53ef\u964d\u4f4e\u80ba\u79fb\u690d\u53d7\u4f53\u7684 \u6025\u6027\u6392\u65a5\u53cd\u5e94\u53d1\u751f\u7387\u3002\u4e5f\u6709\u7814\u7a76\u91c7\u7528\u6b64\u65b9\u6cd5\u6cbb\u7597\u80ba \u79fb\u690d\u672f\u540e\u5e76\u53d1\u6162\u6027\u79fb\u690d\u7269\u5931\u529f\u7684\u53d7\u4f53,\u53d1\u73b0\u5176\u53ef\u6709 \u6548\u5ef6\u7f1330%\u6162\u6027\u79fb\u690d\u7269\u5931\u529f\u53d7\u4f53\u7684\u6392\u65a5\u53cd\u5e94\u8fdb\u7a0b, \u5e76\u5efa\u8bae\u5e94\u5728\u65e9\u671f\u5373\u5f00\u59cb\u5e94\u7528\uff3b20\uff3d\u3002\r\n2\t\u80ba\u79fb\u690d\u624b\u672f\u6cbb\u7597\r\n\u80ba\u79fb\u690d\u624b\u672f\u5e72\u9884\u6587\u732e\u751a\u5c11\u3002\u56fd\u5185\u4ec5\u67091\u7bc7, \u901a\u8fc7\u5bf9\u80ba\u51cf\u5bb9\u624b\u672f\u3001\u5355\u80ba\u79fb\u690d\u672f\u3001\u53cc\u80ba\u79fb\u690d\u672f3\u79cd \u4e0d\u540c\u624b\u672f\u65b9\u5f0f\u6cbb\u7597\u7ec8\u672b\u671f\u80ba\u6c14\u80bf\u7684\u4e34\u5e8a\u7597\u6548\u8fdb\u884c \u5bf9\u6bd4\u53d1\u73b0,\u80ba\u79fb\u690d\u672f(\u5355\u80ba\u3001\u53cc\u80ba)\u60a3\u8005\u80ba\u529f\u80fd\u3001 \u8840\u6c14\u5206\u6790\u6307\u6807\u30016 min\u6b65\u884c\u8ddd\u79bb\u5747\u663e\u8457\u4f18\u4e8e\u80ba\u51cf\u5bb9 \u60a3\u8005,\u8bf4\u660e\u76f8\u5bf9\u4e8e\u4f20\u7edf\u7684\u80ba\u51cf\u5bb9\u624b\u672f,\u80ba\u79fb\u690d\u672f \u80fd\u66f4\u6709\u6548\u7684\u63d0\u5347\u60a3\u8005\u5fc3\u80ba\u8010\u529b,\u6539\u5584\u672f\u540e\u751f\u6d3b\u8d28 \u91cf12\u53e3\u3002Lin\u7b49\u301422\u3015\u5bf960\u4f8b\u53cc\u80ba\u79fb\u690d\u60a3\u8005\u79fb\u690d\u518d\u704c \u6ce8\u524d\u8fdb\u884c\u4e0b\u80a23\u4e2a\u5faa\u73af\u7684\u8fdc\u7a0b\u7f3a\u8840\u8c03\u7406(remote ischemic conditioning, RIC ),\u53d1\u73b0 RIC \u867d\u7136\u53ef\u964d\u4f4e \u7f3a\u8840\u518d\u704c\u6ce8\u635f\u4f24,\u5374\u4e0d\u80fd\u964d\u4f4e\u6025\u6027\u6392\u65a5\u53cd\u5e94\u53ca\u539f\u53d1 \u6027\u79fb\u690d\u7269\u529f\u80fd\u969c\u788d\u7684\u53d1\u751f\u7387\u3002\r\n3\t\u80ba\u79fb\u690d\u672f\u540e\u5eb7\u590d\u6cbb\u7597\r\n\u968f\u7740\u4fc3\u8fdb\u672f\u540e\u6062\u590d(enhanced recovery after surgery, ERAS)\u7406\u5ff5\u7684\u6df1\u5165\uff0c\u80ba\u5eb7\u590d\u5df2\u6210\u4e3a\u80ba\u79fb\u690d\u672f\u540e\u7ba1 \u7406\u7684\u91cd\u8981\u90e8\u5206\uff0c2013\u5e74\u7f8e\u56fd\u80f8\u79d1\u5b66\u4f1a(American Thoracic Society, ATS )\u548c\u6b27\u6d32\u547c\u5438\u5b66\u4f1a(European R espiratory Society, ERS )\u7ed9\u51fa\u4e86\u80ba\u5eb7\u590d\u7684\u5b9a\u4e49: \u80ba\u5eb7\u590d\u662f\u4e00\u79cd\u57fa\u4e8e\u5bf9\u60a3\u8005\u5168\u9762\u8bc4\u4f30\u5e76\u91cf\u8eab\u5b9a\u5236\u7684\u7efc \u5408\u5e72\u9884\u63aa\u65bd,\u5176\u5305\u62ec\u4f46\u4e0d\u9650\u4e8e\u8fd0\u52a8\u8bad\u7ec3\u3001\u6559\u80b2\u548c\u884c \u4e3a\u6539\u53d8,\u65e8\u5728\u63d0\u9ad8\u60a3\u8005\u751f\u7406\u5fc3\u7406\u72b6\u51b5,\u5e76\u4fc3\u4f7f\u60a3\u8005 \u957f\u671f\u575a\u6301\u4fc3\u8fdb\u5065\u5eb7\u7684\u6d3b\u52a8\uff3b23-24\uff3d\u3002\u76f8\u5173\u6587\u732e\u5747\u8868\u660e \u80ba\u79fb\u690d\u672f\u540e\u5eb7\u590d\u5e72\u9884\u53ef\u4ee5\u663e\u8457\u63d0\u5347\u60a3\u8005\u8fd0\u52a8\u8010\u529b, \u63d0\u9ad8\u751f\u5b58\u8d28\u91cf\u3002Fuller\u7b49\u301425\u3015\u901a\u8fc7\u5bf9\u80ba\u79fb\u690d\u672f\u540e\u53d7 \u4f53\u8fdb\u884c7 \u5468\u53ca14\u5468\u7684\u5eb7\u590d\u5e72\u9884\u5bf9\u6bd4\u53d1\u73b0,\u672f\u540e\u534a \u5e74\u65f6\u5eb7\u590d\u7ec4\u7684\u53d7\u4f53\u516d\u5206\u949f\u6b65\u884c\u8ddd\u79bb\u3001\u80a1\u56db\u5934\u808c\u808c\u529b\u3001 \u8158\u7ef3\u808c\u808c\u529b\u53ca\u751f\u6d3b\u8d28\u91cf\u8f83\u57fa\u7ebf\u5747\u6709\u660e\u663e\u63d0\u9ad8\u3002\u7814\u7a76 \u53d1\u73b0\u901a\u8fc7\u5bf9\u80ba\u79fb\u690d\u672f\u540e3d\u7684\u53d7\u4f53\u8fdb\u884c\u80f8\u90e8\u7269\u7406\u6cbb \u7597\u53ca\u9ad8\u9891\u7387\u80f8\u58c1\u632f\u8361\uff0c\u5bf9\u6bd4\u663e\u793a\u4e24\u7ec4\u7684Borg\u8bc4\u5206 \u53ca\u547c\u6c14\u5cf0\u6d41\u901f\u65e0\u663e\u8457\u5dee\u5f02,\u4f46\u9ad8\u9891\u7387\u80f8\u58c1\u632f\u8361\u7ec4\u53d7 \u4f53\u7684SPOJFiO?\u66f4\u4f18\u3001\u75bc\u75db\u8bc4\u5206\u66f4\u4f4e\u3001\u4e14\u60a3\u8005\u6cbb\u7597 \u63a5\u53d7\u5ea6\u66f4\u9ad8\u301426-27\u3015\u3002\u53e6\u6709\u6587\u732e\u8868\u660e,\u5168\u8eab\u632f\u52a8\u8bad\u7ec3 \u4e5f\u53ef\u4ee5\u63d0\u5347\u53d7\u4f53\u7684\u5fc3\u80ba\u8010\u529b,\u63d0\u9ad8\u751f\u6d3b\u8d28\u91cf\u301428-29\u3015\u3002\r\n4\t\u80ba\u79fb\u690d\u672f\u540e\u62a4\u7406\r\n\u80ba\u79fb\u690d\u672f\u540e\u62a4\u7406\u5728\u4f20\u7edf\u7684\u62a4\u7406\u57fa\u7840\u4e0a,\u5f15\u5165\u5e73 \u677f\u7535\u8111\u6559\u80b2,\u4e0e\u4f20\u7edf\u6559\u80b2\u76f8\u6bd4,\u514d\u75ab\u6291\u5236\u5242\u7684\u6d53 \u5ea6\u6c34\u5e73\u53d8\u5f02\u7387\u5c0f,\u4e0d\u826f\u4e8b\u4ef6\u53d1\u751f\u7387\u66f4\u4f4e\u301430\u3015,\u901a\u8fc7 \u836f\u7269\u81ea\u6211\u5904\u7f6e\u7a0b\u5f0f\u8bad\u7ec3,\u60a3\u8005\u7684\u670d\u836f\u4f9d\u4ece\u6027\u66f4\u9ad8, \u80fd\u66f4\u597d\u5730\u7ef4\u62a4\u79fb\u690d\u80ba\u529f\u80fd\u301431\u3015,\u901a\u8fc7\u8ba1\u7b97\u673a\u8d1d\u53f6\u65af \u5206\u6d41\u4e0e\u62a4\u58eb\u5206\u6d41\u7814\u7a76\u5bf9\u6bd4,\u53d1\u73b0\u4e24\u7ec4\u60a3\u8005\u80ba\u529f\u80fd\u548c \u751f\u5b58\u8d28\u91cf\u6ca1\u6709\u660e\u663e\u5dee\u5f02\u301432\u3015\u3002\u603b\u4e4b,\u501f\u52a9\u53d7\u4f53\u81ea\u8eab \u667a\u80fd\u8bbe\u5907\u7ec8\u7aef\u53cd\u9988\u3001\u4e13\u79d1\u62a4\u7406\u3001\u81ea\u6211\u62a4\u7406\u3001\u8ba4\u77e5\u884c \u4e3a\u5e72\u9884\u3001\u5bb6\u5ead\u80ba\u529f\u80fd\u76d1\u6d4b\u53ca\u7b49\u63aa\u65bd,\u4f7f\u53d7\u4f53\u53ef\u4ee5 \u5c3d\u65e9\u53d1\u73b0\u673a\u4f53\u5f02\u5e38\u5e76\u4e14\u5c3d\u65e9\u5c31\u533b,\u51cf\u5c11\u4f4f\u9662\u6b21\u6570\u3001 \u964d\u4f4e\u5e76\u53d1\u75c7\u53d1\u751f\u7387\u3001\u63d0\u5347\u751f\u5b58\u8d28\u91cf,\u540c\u65f6\u53ef\u4ee5\u8282\u7701 \u62a4\u7406\u4eba\u5458\u4eba\u529b\u6295\u5165,\u63d0\u9ad8\u5de5\u4f5c\u6548\u7387\u301432-33\u3015\u3002\r\n5\t\u80ba\u79fb\u690d\u672f\u540e\u75bc\u75db\u6cbb\u7597\r\n\u7814\u7a76\u53d1\u73b0\u901a\u8fc7\u5bf9\u80ba\u79fb\u690d\u672f\u540e\u53d7\u4f53\u8fdb\u884c\u5355\u4fa7\u6216\u53cc \u4fa7\u7f57\u54cc\u5361\u56e0\u80f8\u690e\u690e\u65c1\u5bfc\u7ba1\u795e\u7ecf\u963b\u6ede,\u76d1\u6d4b\u60a3\u8005\u75bc \u75db\u8bc4\u5206\u3001\u963f\u7247\u7c7b\u836f\u7269\u4f7f\u7528\u60c5\u51b5\u53ca\u4e0d\u826f\u4e8b\u4ef6\u53d1\u751f\u7387, \u53d1\u73b0\u80f8\u690e\u690e\u65c1\u5bfc\u7ba1\u795e\u7ecf\u963b\u6ede\u53ef\u4ee5\u663e\u8457\u964d\u4f4e\u60a3\u8005\u75bc\u75db \u8bc4\u5206,\u9547\u75db\u6548\u679c\u826f\u597d\u301434\u3015\u3002\r\n6\t\u5c0f \u7ed3\r\n\u901a\u8fc7\u603b\u7ed3\u80ba\u79fb\u690d\u672f\u540e\u7efc\u5408\u533b\u7597\u5e72\u9884\u7684\u6700\u65b0\u56fd\u5185 \u5916\u7814\u7a76,\u53d1\u73b0\u80ba\u79fb\u690d\u672f\u540e\u5e72\u9884\u624b\u6bb5\u79cd\u7c7b\u591a\u6837,\u5305\u62ec \u836f\u7269\u3001\u624b\u672f\u65b9\u5f0f\u3001\u5eb7\u590d\u5e72\u9884\u3001\u62a4\u7406\u5e72\u9884\u7b49\u591a\u65b9\u9762, \u5404\u79cd\u5e72\u9884\u624b\u6bb5\u53ef\u6709\u6548\u964d\u4f4e\u53d7\u4f53\u672f\u540e\u5e76\u53d1\u75c7\u53d1\u751f\u7387\u3001 \u63d0\u9ad8\u53d7\u4f53\u7684\u751f\u5b58\u8d28\u91cf\u3002\r\n\u53c2\u8003\u6587\u732e\r\n\u3014\t1\u3015 Adamali HI,Judge EP,Healy D,et al. International collaboration\uff1a a retrospective study examining the survival of Irish citizens following lung transplantation in both the UK and Ireland\u3014J\u3015 . BMJ Open, 2012, 2(2)\uff1a e000605.\r\n\u3014\t2\u3015 Lund LH,Edwards LB,Kucheryavaya AY,et al. The registry of the international society for heart and lung transplantation\uff1a thirty-second official adult heart transplantation report\u2014 2015,focus theme\uff1aearly graft failure\u3014J\u3015 . J Heart Lung Transplant,2015, 34(10)\uff1a1244-1254.\r\n\u3014\t3\u3015 Dorgan DJ,Hadjiliadis D. Lung transplantation in patients with cystic fibrosis\uff1a special focus to infection and comorbidities\u3014J\u3015 . Expert Rev Respir Med,2014,8(3)\uff1a 315-326.\r\n\u3014\t4\u3015 Yusen RD,Edwards LB,Kucheryavaya AY,et al. The registry of the international society for heart and lung transplantation\uff1a thirty-second official adult lung and heart-lung transplantation report\u2014 2015\uff1bfocus theme\uff1a early graft failure\u3014J\u3015 . J Heart Lung Transplant, 2015, 34(10)\uff1a 1264-1277.\r\n\u3014\t5\u3015 Formica RN Jr,Lorber KM,Friedman AL, et al. The evolving experience using everolimus in clinical transplantation\u3014J\u3015 . Transplant Proc,2004,36(2 Suppl)\uff1a 495s-499s.\r\n\u3014\t6\u3015 Strueber M,Warnecke G,Fuge J, et al. Everolimus versus mycophenolate mofetil de novo after lung transplantation\uff1a A prospective, randomized, open-label trial\u3014J\u3015 . Am J Transplant,\r\n\u300a\u5b9e\u7528\u5668\u5b98\u79fb\u690d\u7535\u5b50\u6742\u5fd7\u300b2019 \u5e74 7 \u6708\u7b2c 7 \u5377\u7b2c 4 \u671f Prac J Organ Transplant (Electronic Version), July 2019, Vol.7, No.4\r\n-319\u30fb\r\n2016\uff0c 16(11)\uff1a 3171-3180.\r\n[\t7] Gullestad L,Eiskjaer H,Gustafsson F, et al. Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial[J] . Transpl Int, 2016, 29(7)\uff1a 819-829.\r\n[\t8] Ahya VN,McShane PJ,Baz MA, et al. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation[J] . J Heart Lung Transplant, 2011, 30(2)\uff1a 175-181.\r\n[\t9] Arora S,Gude E,Sigurdardottir V, et al. Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients\uff1a the significance of baseline glomerular filtration rate[J] . J Heart Lung Transplant, 2012,31(3)\uff1a 259-265.\r\n[10]\tTreede H,Glanville AR,Klepetko W, et al. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome\uff1a results of a prospective, randomized international trial in lung transplantation[J] . J Heart Lung Transplant, 2012, 31(8)\uff1a 797-804.\r\n[11]\tZaas AK,Alexander BD. New developments in the diagnosis and treatment of infections in lung transplant recipients[J] . Respir Care Clin N Am,2004,10(4)\uff1a 531-547.\r\n[12]\tHatt K,Kinback NC,Shah A , et al. A review of lung transplantation and its implications for the acute inpatient rehabilitation team[J] . Pm r, 2017, 9(3)\uff1a 294-305.\r\n[13]\tVos R,Vanaudenaerde BM,Verleden SE, et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation[J] . Eur Respir J, 2011, 37(1)\uff1a 164-172.\r\n[14]\tFinlen Copeland CA,Davis WA,Snyder LD, et al. Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation\uff1a a singlecenter, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial[J] . J Heart Lung Transplant,2011,30(9)\uff1a 990-996.\r\n[15]\tHusain S,Capitano B,Corcoran T, et al. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex( Abelcet\uff1bABLC) in lung transplant recipients[J] . Transplantation,2010,90(11)\uff1a 1215-1219.\r\n[16]\tMonforte V,Roman A,Gavalda J, et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation\uff1a study of risk factors[J] . J Heart Lung Transplant,2001,20(12)\uff1a 1274-1281.\r\n[17]\tEnderby CY,Heckman MG,Thomas CS, et al. Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole\uff1a a preliminary prospective study[J] . Clin Transplant,2014,28(8)\uff1a 911-915.\r\n[18]\tMoreno I,Mir A,Vicente R,et al. Analysis of interleukin-6 and interleukin-8 in lung transplantation\uff1a correlation with nitric oxide administration[J] . Transplant Proc, 2008, 40(9)\uff1a3082-3084.\r\n[19]\tHartwig MG,Snyder LD,Appel JZ 3rd, et al. Rabbit antithymocyte globulin induction therapy does not prolong survival after lung transplantation[J] . J Heart Lung Transplant,2008, 27(5)\uff1a 547-553.\r\n[20]\tIzhakian S,Wasser WG,Fox BD, et al. Effectiveness of rabbit\r\nantithymocyte globulin in chronic lung allograft dysfunction[J] . Transplant Proc, 2016, 48(6)\uff1a 2152-2156.\r\n[21]\t\u9648\u9896,\u9648\u9759\u745c,\u738b\u632f\u5174.\u80ba\u79fb\u690d\u4e0e\u80ba\u51cf\u5bb9\u672f\u6cbb\u7597\u7ec8\u672b\u671f\u80ba\u6c14\u80bf \u7684\u7597\u6548\u5206\u6790[J].\u4e2d\u56fd\u80f8\u5fc3\u8840\u7ba1\u5916\u79d1\u4e34\u5e8a\u6742\u5fd7,2012,19(2)\uff1a 141-144.\r\n[22]\tLin E,Snell GI,Levvey BJ, et al. Safety, feasibility, and effect of remote ischemic conditioning in patients undergoing lung transplantation[J] . J Heart Lung Transplant,2014,33(11)\uff1a 1139-1148.\r\n[23]\tSpruit MA,Singh SJ,Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement\uff1a key concepts and advances in pulmonary rehabilitation[J] . Am J Respir Crit Care Med,2013,188(8)\uff1a e13-64.\r\n[24]\t\u82d7\u9752\uff0c\u97e9\u8273\u6ce2,\u5f20\u91d1\u51e4.\u300aATS/ERS\u5171\u8bc6:\u80ba\u5eb7\u590d\u8981\u70b9\u4e0e\u8fdb\u5c55\u300b \u4e2d\u80ba\u5eb7\u590d\u8fd0\u52a8\u5904\u65b9\u89e3\u8bfb[J].\u5b9e\u7528\u5fc3\u8111\u80ba\u8840\u7ba1\u75c5\u6742\u5fd7,2017, 25(1)\uff1a1-3.\r\n[25]\tFuller LM,Button B,Tarrant B, et al. Longer versus shorter duration of supervised rehabilitation after lung transplantation\uff1a A randomized trial[J] . Arch Phys Med Rehabil,2017,98(2)\uff1a 220-226.e3.\r\n[26]\tEsguerra-Gonzales A,Ilagan-Honorio M,Kehoe P,et al. Effect of high-frequency chest wall oscillation versus chest physiotherapy on lung function after lung transplant[J] . Appl Nurs Res,2014, 27(1)\uff1a 59-66.\r\n[27]\tEsguerra-Gonzalez A,Ilagan-Honorio M,Fraschilla S, et al. CNE article\uff1a pain after lung transplant\uff1a high-frequency chest wall oscillation vs chest physiotherapy[J] . Am J Crit Care,2013, 22(2)\uff1a 115-124.\r\n[28]\tGloeckl R,Heinzelmann I,Seeberg S, et al. Effects of complementary whole-body vibration training in patients after lung transplantation\uff1a A randomized, controlled trial[J] . J Heart Lung Transplant,2015,34(11)\uff1a 1455-1461.\r\n[29]\t\u738b\u6734, \u96d2\u6653\u751c, \u5f20\u9a70, \u7b49. \u5168\u8eab\u632f\u52a8\u8bad\u7ec3\u5bf9\u5fc3\u80ba\u529f\u80fd\u5f71\u54cd\u7684\u7814 \u7a76\u8fdb\u5c55[J].\u4e2d\u56fd\u5eb7\u590d\u533b\u5b66\u6742\u5fd7\uff0c2017,32(1)\uff1a 117-120.\r\n[30]\tSuhling H,Rademacher J,Zinowsky I,et al. Conventional vs. tablet computer-based patient education following lung transplantation--a randomized controlled trial[J] . PLoS One, 2014, 9(6)\uff1a e90828.\r\n[31]\t\u66f9\u6653\u4e1c,\u6731\u4ead\u7acb,\u9ec4\u4e91\u5a1f,\u7b49.\u836f\u7269\u81ea\u6211\u5904\u7f6e\u7a0b\u5f0f\u8bad\u7ec3\u5bf9\u80ba\u79fb\u690d \u672f\u540e\u75c5\u4eba\u670d\u836f\u4f9d\u4ece\u6027\u3001\u80ba\u529f\u80fd\u548c\u793e\u4f1a\u529f\u80fd\u7684\u5f71\u54cd[J ].\u62a4\u7406\u7814 \u7a76,2014,28(34)\uff1a4295-4298.\r\n[32]\tFinkelstein SM, Lindgren BR, Robiner W,et al. A randomized controlled trial comparing health and quality of life of lung transplant recipients following nurse and computer-based triage utilizing home spirometry monitoring[J] . Telemed J E Health, 2013,19(12)\uff1a897-903.\r\n[33]\tDeVito Dabbs A,Song MK,Myers BA, et al. A randomized controlled trial of a mobile health intervention to promote selfmanagement after lung transplantation[J] . Am J Transplant, 2016,16(7)\uff1a2172-2180.\r\n[34]\tHutchins J,Apostolidou I,Shumway S,et al. Paravertebral catheter use for postoperative pain control in patients after lung transplant surgery\uff1a A prospective observational study[J] . J Cardiothorac Vasc Anesth,2017,31(1)\uff1a142-146..\r\n(\u6536\u7a3f\u65e5\u671f\uff1a2018-08-15)\r\n\u9093\u6dd1\u5764\uff0c\u9f9a\u71d5\u534e\uff0c\u5468\u4ef2\u534e\uff0c\u8881\u9e4f.\u80ba\u79fb\u690d\u672f\u540e\u6cbb\u7597\u7684\u7814\u7a76\u8fdb\u5c55[J/CD].\u5b9e\u7528\u5668\u5b98\u79fb\u690d\u7535\u5b50\u6742\u5fd7,2019,7(4):317-319.\r\n\n"}